InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.
MGuard Prime features superior flexibility and excellent deliverability and has found to be comparable to the XIENCE V stent when tested for deliverability through a double curved path model. MGuard Prime is indicated for Primary PCI for STEMI, Saphenous Vein Grafts and ACS with visible thrombus. The new MGuard PRIME is CE Marked and will be available in 2011 in selected territories.
AI-driven algorithm accurately predicts death, complications after percutaneous coronary intervention